Cannabinoids, Data, Patients and THC - Medical Cannabis Brief

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Participants inhaled a precise dose containing either THC (at doses of either 0.5mg or 1mg) or placebo.

Clinical Trials

Clinical Trials Chronic Pain Cannabinoids Patients

Cannabinoids for Tinnitus?

Project CBD

MARCH 21, 2023

The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus. And its conclusion?

Cannabinoids

Cannabinoids Clinical Trials Sleep Blood Pressure

THC & CBD-Rich Cannabis for Fibromyalgia

Project CBD

FEBRUARY 27, 2023

Instead, patients turn to a mix of whatever individual medications, therapies, and lifestyle changes (especially exercise) help ease symptoms and improve quality of life. “Available data strongly support the use of cannabinoids in treating fibromyalgia pain” due to “overwhelmingly positive treatment results.”

THC

THC CBD Sleep Clinical Trials

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

NORML

FEBRUARY 25, 2020

Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.

Clinical Trials

Clinical Trials THC Consumption Therapy

Real world data: CBD with CBN, THC, and melatonin is a winning formula for sleep

The Cannigma

SEPTEMBER 18, 2023

So it’s not surprising that products that combine cannabis and melatonin are making their way into legal marketing – and according to real world data gathered in a recent campaign on The Cannigma, it’s a winning combination. Or as one participant testified, “I like that the THC content is low (I’m a lightweight ?)

Sleep

Sleep Data THC CBD

Cannabis consumers, real-world data, and why it matters

The Cannigma

OCTOBER 22, 2023

The Cannigma has always taken a data-informed approach to content creation – though up until recently we’ve been primarily leaning on the existing peer-reviewed literature to guide our content. We need more data – human data – on specific applications for the plant – symptoms, use cases, conditions and patient types.

Data

Data Research and Development Sleep Collective

Could CBN really help you sleep? Consumer study data suggest yes.

The Cannigma

APRIL 12, 2023

CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. Like THC , CBN is a natural anti-inflammatory. Here’s what they found.

Sleep

Sleep Data Tincture Research and Development

Gut Feeling

Project CBD

JUNE 20, 2023

In a newly published survey of 162 IBD patients in Puerto Rico, where medical cannabis is legal but recreational use is punishable with prison time , about 25% anonymously reported using cannabis to treat their symptoms. Findings from another recent survey of New York and Minnesota medical cannabis dispensary patients were similar.

Cannabinoids

Cannabinoids Patients Treatment Conditions

ICRS 2023: Report from Toronto

Project CBD

AUGUST 9, 2023

I counted over 175 talks and posters at the 33rd annual gathering of the International Cannabinoid Research Society (ICRS), which convened in Toronto at the end of June. In accordance with longstanding ICRS policy, all speakers presented new findings and data that had not yet been published in a peer-reviewed journal.

Cannabinoids

Cannabinoids THC CBD Blood Pressure

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

Cannabis Law Report

DECEMBER 2, 2021

The investigational new drug, IGC-AD1, is IGC’s proprietary Tetrahydrocannabinol (THC)-based candidate designed to treat certain symptoms of Alzheimer’s disease. Over 70% of these patients face one or more debilitating symptoms, including anxiety, depression, and agitation (Mendez, 2021). million individuals in the U.S.

Clinical Trials

Clinical Trials Data Patients THC

Medical Marijuana Patients Use Less ADHD Medication

CannaMD

OCTOBER 14, 2020

A study published earlier this year reveals a simple but interesting pattern: When patients with ADHD consume more cannabis, they require fewer prescription drugs. According to the study’s research team , patients who consume medical marijuana report a “higher occurrence of stopping all ADHD medications.”

Patients

Patients Marijuana Cannabinoids Terpenes

Nevada veterinarians can now treat patients with certain cannabis products

Cannabis Law Report

SEPTEMBER 12, 2021

Steve Sisolak signed Assembly Bill 101, making Nevada the first state to legalize the use of cannabinoids as a veterinary treatment. or less THC are exempted from the federal Controlled Substances Act, the products do fall under the Federal Food, Drug, and Cosmetic Act if they are used therapeutically or included in animal food.

Patients

Patients Pets Seed-To-Sale Cannabinoids

Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

Cannabis Law Report

DECEMBER 14, 2021

(“IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease. There were three Cohorts, with 12 patients in each cohort.

Clinical Trials

Clinical Trials Safety Data Patients

THC Provides More Symptom Relief Than CBD, According To New Study

MassRoots

MARCH 5, 2019

Cannabidiol ( CBD ), the non-psychoactive cannabinoid praised for medicinal powers like reducing the severity and frequency of seizures in children suffering from rare and otherwise untreatable forms of epilepsy, may not be the most medically beneficial molecule found in cannabis, according to new data. Data Tracking.

THC

THC CBD Data Cannabinoids

Survey Reveals Almost Half of Canada’s MMJ Patients Reduced Their Alcohol and Opioid Consumption

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. As of 2020, the market was worth CAD $2.6 billion (USD $2 billion).

Consumption

Consumption Patients Research and Development Data

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Cannabis Law Report

JUNE 7, 2021

IGC”) (NYSE American: IGC) announces today that it has completed Cohort 2 of its Phase 1 clinical trial on IGC’s tetrahydrocannabinol (“THC”)-based investigational new drug, IGC-AD1, intended to alleviate the symptoms of individuals suffering from Alzheimer’s disease. As previously disclosed, IGC submitted IGC-AD1 to the U.S. www.igcinc.us

Clinical Trials

Clinical Trials Patients THC Safety

Getting to Know Cannabigerol with Bonni Goldstein, MD

Project CBD

MAY 3, 2023

Dr. Goldstein has treated thousands of patients with medical cannabis. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids.

Cannabinoids

Cannabinoids Sleep Clinical Trials CBD

Migraine Patients: 82% Say Marijuana Works

CannaMD

NOVEMBER 4, 2020

According to a recent study published in the Journal of Headache Pain , across 2,032 patients and 21 illnesses, headache was a symptom treated with cannabis in 24.9% (505) of cases, while 88% (445) of headache patients treated probable migraines with cannabis. 30 percent of migraine patients in the U.S. The results?

Patients

Patients Chronic Pain Marijuana Research and Development

FDA Publish Article “5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC”

Cannabis Law Report

SEPTEMBER 15, 2021

More than 100 people in the US have been hospitalized in 2021 after using Delta-8 THC products, federal health regulators warned Tuesday. Delta-8 tetrahydrocannabinol, also known as delta-8 THC, is a psychoactive substance found in the Cannabis sativa plant, of which marijuana and hemp are two varieties. brownies, gummies).

THC

THC Pets Events Hemp

Researchers at People Science Explore the Effects of Cannabinoids on Sleep

Veriheal

FEBRUARY 28, 2023

Technology-enabled clinical research company People Science is carrying out a study into the effects of cannabinoids on sleep behavior. The oil contained 10 mg/ml tetrahydrocannabinol (THC) and 15 mg/ml cannabidiol (CBD). A 2021 study investigated how THC and CBD (in the form of edibles) influenced a consumer’s sleep cycle.

Sleep

Sleep Cannabinoids Food Data

Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It

The Cannigma

FEBRUARY 2, 2021

In a new survey of German patients with Parkinson’s disease, 8% of patients reported using cannabis products. However, the survey also revealed that, among the Parkinson’s disease patients , there was a noticeable knowledge gap concerning the different methods of consumption available and the individual effects of THC and CBD.

Patients

Patients Clinical Trials Research and Development Treatment

Cannabis as a cancer cure: what is the research and where is it going?

The Cannigma

FEBRUARY 1, 2023

Patients are often left to their own devices when looking into cannabis and cancer, given the lack of clinical evidence, and stigma surrounding the use of the plant as medicine. Even if a cannabinoid has shown promise on one cancer line, that doesn’t mean it will work for all cancers – even if it’s within the same organ system.

Clinical Trials

Clinical Trials Research and Development Therapy Cannabinoids

Finding ‘Releaf’: Put Data in Your Pipe and Smoke It

The Cannigma

JANUARY 16, 2021

Listen & Subscribe: Finding the right cannabis product can be a daunting task for anyone, let alone a new medical patient without any guidance. Anonymized data also helps scientists better understand the cannabis plant and what products and chemical profiles are most effective for treating different conditions and symptoms.

Data

Data Research and Development Patients Strains

New Study Shows Medical Cannabis Syqe Inhaler Significantly Reduced Pain in Neuropathy Patients

Veriheal

SEPTEMBER 16, 2022

Recent research has found that aerosolized cannabis can provide long-term pain reduction, specifically in patients with neuropathy and other chronic conditions. This device ensures that patients get metered and precise doses of cannabis. Study Assesses Analgesic Potential of Medical Cannabis for Neuropathy Patients.

Patients

Patients Chronic Pain Research and Development Treatment

Study: Cannabinoids Effective for Post Traumatic Stress Patients

The Joint Blog

MARCH 18, 2021

According to a new study titled Use of cannabinoids for the treatment of patients with post-traumatic stress disorder, the consumption of cannabinoids and cannabinoid products is safe and effective in the mitigation of symptoms of post-traumatic stress (PTS).

Cannabinoids

Cannabinoids Patients Clinical Trials Research and Development

Sleep issues? Free THC+CBN+CBD gummies for sleep study

The Cannigma

JULY 5, 2023

Join a sleep study and help advance real world data Yes, cannabis has an age-old reputation as a sleep aid, but the scientific evidence supporting its use is still shaky, and anecdotal reports are inconclusive. We need more data so consumers can make better decisions – both on an individual level, and as a community at large.

Sleep

Sleep THC CBD Blood Pressure

Research Shows Chronic Pain Patients See Sustained Improvement With Cannabis Use

SpeedWeed

APRIL 10, 2021

Chronic pain patients who used cannabis saw sustained improvement in their condition over time, according to the results of a recently released study. The data revealed a sustained improvement in the participants’ symptoms. Different Effects Noted For THC, CBD. An abstract of the research, “No pain, all gain?

Chronic Pain

Chronic Pain Patients Treatment Data

Data is Knowledge with Otha Smith III

The Cannigma

NOVEMBER 23, 2021

Listen & Subscribe: Finding the correct dosage and combination of cannabinoid products for medical treatment is almost universally a long and expensive process of trial and error. And for the most part, patients are undertaking this journey alone and often with little guidance.

Data

Data Patients Access Wellness and Beauty

IMPORTANT HEALTH MESSAGE: Don’t mix THC with COVID-19, Aurelius researchers say

Cannabis Law Report

MARCH 22, 2020

Mugglehead reports… Previous tests with THC in mice with influenza showed an increase in viral loads. A data firm is warning those infected with the novel coronoavirus to avoid consuming products that contain tetrahydrocannabinol (THC), the main psychoactive component of cannabis. World Health Organization (WHO).

THC

THC Clinical Trials Data Consumption

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events.

Safety

Safety Cannabinoids Events Data

Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

Veriheal

AUGUST 12, 2021

Patients who suffer from epilepsy , which affects some 3.4 million people across the United States , report experiencing improved quality of life and a more restful night’s sleep after consuming the non-psychoactive cannabinoid CBD (cannabidiol). Researchers Analyzed Survey Results from 280 Epilepsy Patients.

Epilepsy

Epilepsy Pharmaceutical Patients Sleep

Quick Hits

Project CBD

JANUARY 24, 2019

Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Previous research has found that THC may be effective for some cases that do not respond well to Ritalin. .

Research and Development

Research and Development Chronic Pain Cannabinoids Treatment

CBD Science Update

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD

CBD Blood Pressure Research and Development Cannabinoids

Prohibitionists want THC-limit laws. Here’s why patients and consumers are fighting back

SpeedWeed

MARCH 6, 2021

Proposals to cap the amount of THC in cannabis flower and concentrates have been gaining traction in a number of state legislatures, and earlier this week the idea reached the federal level. Most cannabis flower in America’s legal regulated markets ranges between 18% and 23% THC. Forcing patients to purchase more.

THC

THC Patients Law Chronic Pain

Do Delta 8 Edibles Work For Female Arousal?

United Patients Group

MAY 7, 2024

To start with, for those who don’t already know, Delta 8 is a cannabinoid in cannabis plants. the most common cannabinoid found in cannabis ). Benefits Of Delta 8 THC Edibles For Female Arousal And Intimacy Delta 8 edibles offer a variety of benefits for women looking to enhance their arousal and intimacy.

Edibles

Edibles Research and Development Cannabinoids THC

Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication

Cannabis Law Report

JANUARY 3, 2022

(Nasdaq: ANEB), a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse, announces that the first patient has been dosed in a Phase 2 proof-of-concept clinical study investigating ANEB-001 as a potential treatment for acute cannabinoid intoxication.

Pharmaceutical

Pharmaceutical Cannabinoids Treatment Clinical Trials

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Cannabis Law Report

JULY 29, 2021

This initial export to Austria marks Avicanna’s first commercial export of psychoactive THC Cannabis Extracts into the emerging European medicinal cannabis market. Initial shipment of THC extracts into the European Union. New progressive regulation on cannabis in Colombia.

Extraction

Extraction Supply Chain THC Research and Development

Study Suggests That THC is More Efficient at Providing Symptomatic Relief for Nausea Than CBD

Veriheal

JULY 5, 2021

Cannabis is brimming with hundreds of active cannabinoids, but just two have really managed to steal the limelight – THC (tetrahydrocannabinol) and CBD (cannabidiol). In spite of their fairly equal dominance in the legal cannabis space—collectively, these cannabinoids racked up $17.5 billion in legal U.S. billion in legal U.S.

THC

THC CBD Treatment Cannabinoids

New Study Shows Cannabis Use May Be Responsible For Improved Health And Quality of Life

MedicalJane

JUNE 12, 2020

Of the 1,276 participants, 524 adult patients and 284 adult caregivers of children or dependent adults, all self-reported using cannabis for medicinal purposes. The control group consisted of 271 adult patients who were considering cannabis use, and 197 adult caregivers who were considering it for a dependent child or adult patient.

Chronic Pain

Chronic Pain Epilepsy Patients Medicine

Insomnia is Treated Effectively with Medical Marijuana

FloridaMarijuana.net

AUGUST 13, 2018

Patients in Florida are receiving medical marijuana for Insomnia, find out if you qualify for medical marijuana in Florida click here. Sleep improvement is a primary motivator for many patients who are utilizing medical cannabis. With high doses of THC (50 to 210 mg) REM sleep was decreased in both regular users and nonusers.

Sleep

Sleep Chronic Pain Marijuana Cannabinoids

Delta-8 THC Has ‘Serious Health Risks’ Warns Two Federal Agencies

SpeedWeed

SEPTEMBER 15, 2021

Vomiting, hallucinations, trouble standing and loss of consciousness are some of the adverse effects associated with consuming hemp-derived products containing delta-8 tetrahydrocannabinol (THC), the U.S. The health effects of delta-8 THC have not yet been researched extensively and are not well-understood,” the CDC stated. “The

THC

THC Blood Pressure Concentrates Events

CBD Science Update

Project CBD

AUGUST 6, 2019

The 29th annual International Cannabinoid Research Society ( ICRS ) symposium, which convened last month in Bethesda, Maryland, featured new developments in CBD science that have far-reaching implications for many areas of medicine. None of the participants had been using any cannabinoid-based products prior to this study.

CBD

CBD Blood Pressure Research and Development Cannabinoids

UNM Study Praises Cannabis as Potential Treatment for Fatigue

Veriheal

AUGUST 15, 2022

Data was pulled from 3,922 cannabis self-administration sessions with the help of this application. Minor Cannabinoids vs. CBD and THC. Scientists know that cannabis contains a wide variety of naturally occurring chemicals other than cannabinoids. Promising News for Endless Patients.

Treatment

Treatment Research and Development Sativa Cannabinoids

Best strains and terpenes for migraine relief

The Cannigma

JANUARY 13, 2023

Based on the limited existing evidence, the best cannabis strain for migraines may be a Type II that includes both THC and CBD, and a terpene profile that includes beta-caryophyllene, myrcene, linalool, limonene, bisabolol, humulene or pinene. 5 THC and migraines THC is well-known for its anti-nausea and pain-relieving effects.

Terpenes

Terpenes Strains THC Treatment

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

Cannabinoids for Tinnitus?

Trending Sources

THC & CBD-Rich Cannabis for Fibromyalgia

Clinical Trial: Oral THC Administration Associated with Opioid-Sparing Effects

Real world data: CBD with CBN, THC, and melatonin is a winning formula for sleep

Cannabis consumers, real-world data, and why it matters

Could CBN really help you sleep? Consumer study data suggest yes.

Gut Feeling

ICRS 2023: Report from Toronto

Phase 1 Clinical Trial Data Indicate IGC’s THC-based Investigational New Drug May Reduce Symptoms of Dementia in Alzheimer’s Patients

Medical Marijuana Patients Use Less ADHD Medication

Nevada veterinarians can now treat patients with certain cannabis products

Clinical Trial on Alzheimer’s Patients Indicates Positive Safety and Tolerability Data for IGC’s THC-Based Investigational New Drug

THC Provides More Symptom Relief Than CBD, According To New Study

Survey Reveals Almost Half of Canada’s MMJ Patients Reduced Their Alcohol and Opioid Consumption

IGC Completes Cohort 2 of its Phase 1 THC-Based Clinical Trial on Alzheimer’s Patients

Getting to Know Cannabigerol with Bonni Goldstein, MD

Migraine Patients: 82% Say Marijuana Works

FDA Publish Article “5 Things to Know about Delta-8 Tetrahydrocannabinol – Delta-8 THC”

Researchers at People Science Explore the Effects of Cannabinoids on Sleep

Cannabis Helps, Say Over Half of Parkinson’s Patients Who Use It

Cannabis as a cancer cure: what is the research and where is it going?

Finding ‘Releaf’: Put Data in Your Pipe and Smoke It

New Study Shows Medical Cannabis Syqe Inhaler Significantly Reduced Pain in Neuropathy Patients

Study: Cannabinoids Effective for Post Traumatic Stress Patients

Sleep issues? Free THC+CBN+CBD gummies for sleep study

Research Shows Chronic Pain Patients See Sustained Improvement With Cannabis Use

Data is Knowledge with Otha Smith III

IMPORTANT HEALTH MESSAGE: Don’t mix THC with COVID-19, Aurelius researchers say

Report: Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis

Study Finds That Non-Pharmaceutical May Boost Quality Of Life Among Epilepsy Patients

Quick Hits

CBD Science Update

Prohibitionists want THC-limit laws. Here’s why patients and consumers are fighting back

Do Delta 8 Edibles Work For Female Arousal?

Anebulo Pharmaceuticals Announces Initiation of Phase 2 Clinical Study Evaluating ANEB-001 for the Treatment of Acute Cannabinoid Intoxication

Avicanna Completes First Commercial Export of Aureus™ Branded THC Extracts to Austria and Welcomes Colombian Government’s Progressive New Regulation on Cannabis

Study Suggests That THC is More Efficient at Providing Symptomatic Relief for Nausea Than CBD

New Study Shows Cannabis Use May Be Responsible For Improved Health And Quality of Life

Insomnia is Treated Effectively with Medical Marijuana

Delta-8 THC Has ‘Serious Health Risks’ Warns Two Federal Agencies

CBD Science Update

UNM Study Praises Cannabis as Potential Treatment for Fatigue

Best strains and terpenes for migraine relief

Stay Connected